abstract |
The invention relates to compounds of Formula (I) and pharmaceutically acceptable acid addition salts thereof, wherein *, X1, X2, R5A, R5B, R6, R7, and R8 are as defined jn the specification; pharmaceutical compositions; therapeutic combinations; uses in the manufacture of medicaments; and methods of treating diseases and disorders. |